Dr Max Jakobs is the CEO and co-founder of deepmirror, a University of Cambridge spin-out that build the largest foundation model for drug design to accelerate drug discovery. He holds a PhD in Physical Biology from the University of Cambridge and has raised $ millions for deepmirror's mission.